Atlantic International Corp.

NASDAQ:ATLN

Medical - Diagnostics & Research

Healthcare
$0.90 -13.84%

-$0.10 today

Market cap
$73.17M
Beta
0.71
P/E (TTM)
-0.6
EPS (TTM)
-$1.08
52W Low $0.60High $5.25

Volume 18.56M

Average 0.44M

ATLN Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Atlantic International Corp.NASDAQ: ATLN

Weighted Avg Shares · Q4 FY2025 · quarter ended Dec 2025

Weighted avg shares grows, but more slowly than its trailing trend

Q4 FY2025 weighted avg shares of 54.85M shares rose 3.2% year over year, behind the +44.0% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.5% from the prior quarter. Over 3 fiscal years it compounded at +36.2% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +3.2% toward the trailing-twelve-month pace of +44.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
54.85M+0.5% QoQ
Last fiscal yearDec 2025
54.85M+49.1% YoY
LTMDec 2025
54.48M+44.0% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.2%——
1 year+49.1%——
3-year CAGR+36.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
54.85M USD
Year-over-year change
+49.1%
4-year CAGR
+26.1%

Weighted Avg Shares vs competitors

How ATLN compares with its peers on the latest reported figures

  • ATLN's LTM Dec 2025 weighted avg shares of 54.48M shares is the 4th highest of the 8 companies compared; the peer median is 44.2M shares.
  • Its year-over-year change of +44.0% is the 3rd highest of 8, against a peer median of +33.0%.
  • Over three fiscal years its annual growth of +36.2% compares with a peer median of +34.8%.
ATLN Competitors Peer median
Weighted Avg Shares for ATLN and competitors
Company Period LTM YoY 3-year CAGR
MISTMilestone Pharmaceuticals Inc.LTM Mar 202686.73M +33.0%+25.5%
NKTXNkarta, Inc.LTM Mar 202674.08M +0.6%+19.3%
STIMNeuronetics, Inc.LTM Mar 202667.96M +71.5%+34.8%
ATLNAtlantic International Corp.LTM Dec 202554.48M +44.0%+36.2%
PEPGPepGen Inc.LTM Mar 202644.2M +35.7%+39.2%
IMDXInsight Molecular Diagnostics Inc.LTM Mar 202632.26M +85.3%+76.5%
AVRAnteris Technologies Global Corp.LTM Mar 202623.58M -20.8%-13.1%
PREPrenetics Global LimitedLTM Mar 202615.04M +18.8%+40.5%
Peer median (excluding ATLN) 44.2M+33.0%+34.8%

Competitors are the stored peer set for ATLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue425.03M441.54M401.37M442.61M435.88M
Cost of Revenue370.62M387.34M354.5M395.43M389.89M
Gross Profit54.41M54.21M46.88M47.18M45.99M
Gross Margin12.8%12.3%11.7%10.7%10.6%
Research & Development00000
Selling, General & Admin42.18M42.27M45.44M64.02M91.29M
Operating Expenses90.14M48.23M50.33M69.01M96.22M
Depreciation & Amortization4.11M5.07M5.04M4.99M6.59M
EBITDA12.18M11.94M1.44M(113.1M)(43.64M)
EBITDA Margin2.9%2.7%0.4%-25.6%-10.0%
Operating Income(35.73M)5.98M(3.45M)(21.83M)(50.23M)
Operating Margin-8.4%1.4%-0.9%-4.9%-11.5%
Interest Income36.46K44.88K000
Interest Expense208.29K90.75K17.54M12M9.16M
Other Income / Expenses(3.73M)(8.39M)(17.73M)(108.27M)(9.16M)
Income Before Tax(39.46M)(2.41M)(21.18M)(130.1M)(59.4M)
Pre-Tax Margin-9.3%-0.5%-5.3%-29.4%-13.6%
Income Tax Expense1.33M808.43K(5.93M)5.38M33.99K
Net Income(40.8M)(3.22M)(15.25M)(135.48M)(59.43M)
Net Margin-9.6%-0.7%-3.8%-30.6%-13.6%
EPS (Basic)(0.17)(0.19)(0.60)(3.68)(1.08)
EPS (Diluted)(0.17)(0.17)(0.60)(3.68)(1.08)
Weighted Avg Shares21.69M21.69M25.42M36.78M54.85M
Weighted Avg Shares (Diluted)21.69M24.14M25.42M36.78M54.85M

Atlantic International Corp.

NASDAQ:ATLN

Intrinsic Alpha fair value

Locked

Current Price

$0.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.